Zymeworks Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ZYME Nasdaq 2836 www.zymeworks.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Zymeworks Inc.

Companies Like Zymeworks (NASDAQ:ZYME) Are In A Position To Invest In Growth - Jun 24th, 2025 4:42 am
Zymeworks Announces NMPA Approval of Zanidatamab in China for Adults with Previously Treated, Unresectable or Metastatic HER2-high expression (IHC3+) Biliary Tract Cancer - May 30th, 2025 4:00 am
Zymeworks Announces Presentations Highlighting Breadth of Oncology Portfolio at Upcoming Medical Conferences - May 22nd, 2025 3:00 pm
Zymeworks Announces Participation in Upcoming Investor Conferences - May 21st, 2025 4:00 am
Zymeworks Presents Preclinical Data on ZW1528 at the American Thoracic Society International Conference - May 19th, 2025 2:15 pm
Analyst Forecasts For Zymeworks Inc. (NASDAQ:ZYME) Are Surging Higher - May 14th, 2025 4:22 am
Zymeworks First Quarter 2025 Earnings: Beats Expectations - May 10th, 2025 6:28 am
Zymeworks Provides Corporate Update and Reports First Quarter 2025 Financial Results - May 8th, 2025 2:05 pm
Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting - Apr 25th, 2025 11:00 am
Zymeworks Appoints Dr. Sabeen Mekan as Senior Vice President, Clinical Development - Apr 21st, 2025 4:00 am
Zymeworks to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025 - Apr 17th, 2025 4:00 am
Zymeworks to Present Preclinical Data on T cell Engager and Antibody-Drug Conjugate Platforms in Six Posters at AACR Annual Meeting - Mar 25th, 2025 2:30 pm
Analysts Just Shipped A Captivating Upgrade To Their Zymeworks Inc. (NASDAQ:ZYME) Estimates - Mar 10th, 2025 4:28 am
Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results - Mar 5th, 2025 2:05 pm
Zymeworks Announces Achievement of $14 Million Milestone from GSK Collaboration - Feb 26th, 2025 4:00 am
Zymeworks Announces Appointment of Oleg Nodelman to Board of Directors - Feb 18th, 2025 4:00 am
Zymeworks To Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on March 5, 2025 - Feb 13th, 2025 4:00 am
The past five years for Zymeworks (NASDAQ:ZYME) investors has not been profitable - Jan 23rd, 2025 3:50 am
Zymeworks Outlines Strategic Priorities and Outlook for 2025 and 2026 - Jan 8th, 2025 2:05 pm
Zymeworks (NASDAQ:ZYME) Is In A Good Position To Deliver On Growth Plans - Dec 13th, 2024 5:12 am